Trials / Completed
CompletedNCT03930004
Preclinical Cardiomyopathy and Autonomic Function in Type 1 Diabetes
Preclinical Cardiomyopathy in Type 1 Diabetes: Correlation With Autonomic Dysfunction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Roberto Léo da Silva · Academic / Other
- Sex
- All
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Type 1 diabetes mellitus is a chronic autoimmune disease, associated with an increased risk of cardiovascular diseases. The development of cardiomyopathy in type 1 diabetes, independent of hypertension and coronary heart disease, is still controversial. A possible mechanism for diabetic cardiomyopathy is autonomic dysfunction. This study aims to evaluate cardiac function and structure, and to relate them with autonomic dysfunction in type 1 diabetes.
Conditions
Timeline
- Start date
- 2018-07-06
- Primary completion
- 2019-08-01
- Completion
- 2019-09-01
- First posted
- 2019-04-29
- Last updated
- 2019-10-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03930004. Inclusion in this directory is not an endorsement.